SCHEMBL8595272

SCHEMBL8595272

CC1=C(C(=O)O)C(c2ccccc2/C=C/C(=O)O)C(C(=O)O)=C(C)N1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.53
LMNA P02545 3/20 0.53
CYP3A4 P08684 2/20 0.53
ADORA3 P0DMS8 2/20 0.53
CYP2C9 P11712 2/20 0.53
TBXAS1 P24557 2/20 0.53
CYP2C19 P33261 2/20 0.53
KCNH2 Q12809 2/20 0.53
NR1I2 O75469 2/20 0.53
PGR P06401 1/20 0.53
SLC6A2 P23975 1/20 0.53
DRD3 P35462 1/20 0.53
OPRK1 P41145 1/20 0.53
PDE4D Q08499 1/20 0.53
NFKB1 P19838 2/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA4 P22748 1/20 0.45
CACNA1B Q00975 7/20 0.43
SMN1; SMN2 Q16637 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8595275 1.00 HTT (0.53) HTTLMNACYP3A4ADORA3CYP2C9
SCHEMBL9871535 0.87 ADORA3 (0.57) HTTLMNACYP3A4ADORA3CYP2C9
SCHEMBL9871528 0.87 ADORA3 (0.57) HTTLMNACYP3A4ADORA3CYP2C9
SCHEMBL9681021 0.86 HTT (0.44) HTTLMNACYP3A4ADORA3CYP2C9
SCHEMBL9681009 0.86 HTT (0.44) HTTLMNACYP3A4ADORA3CYP2C9
SCHEMBL9680023 0.84 ADORA3 (0.74) HTTLMNACYP3A4ADORA3CYP2C9
SCHEMBL9680033 0.84 ADORA3 (0.74) HTTLMNACYP3A4ADORA3CYP2C9
SCHEMBL9871872 0.84 ADORA3 (0.67) HTTLMNACYP3A4ADORA3CYP2C9
SCHEMBL9871869 0.84 ADORA3 (0.67) HTTLMNACYP3A4ADORA3CYP2C9
SCHEMBL9681769 0.84 LMNA (0.44) HTTLMNACYP3A4ADORA3CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0370974-B1 Process for preparing heterocyclic derivatives GLAXO WELLCOME SPA (IT) 1998-01-21 EP disclosed
EP-0370974-A2 Process for preparing heterocyclic derivatives GLAXO S.p.A. (IT) 1990-05-30 EP disclosed
US-4801599-A CARDIOVASCULAR DISORDERS, HYPOTENSIVE AGENTS GLAXO S.P.A. (IT) 1989-01-31 US disclosed